HDAC6 and neoplasm: When tumor sizes reached ≈50 mm3, mice received intraperitoneal injections of HDAC6 inhibitor Tubastatin A (TubA) or vehicle every two days at a dose of 25 mg kg day−1 (Figure S7B, Supporting Information).[34] After three weeks of treatment, mice tumors were collected and recorded.